AQST vs CHRW · rev $28.3M vs P/E 37, rev $8.95B
Aquestive Therapeutics Inc (AQST) versus CH Robinson Worldwide Inc (CHRW) — a side-by-side from cached financials, not a winner call.
Aquestive Therapeutics Inc (AQST) is a drug manufacturers - specialty & generic company listed on US.
CH Robinson Worldwide Inc (CHRW) is a integrated freight & logistics company listed on US.
Latest reported AQST revenue for 2026-06-30 was $28.3M. Net income was -$30.9M. Revenue was up 95.7% from 2026-03-31 to 2026-06-30. AQST currently screens at market cap $493.0M.
Latest reported CHRW revenue for 2026-06-30 was $8.95B. Net income was $334.0M. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
AQST currently screens at market cap $493.0M. CHRW currently screens at market cap $21.70B and trailing P/E 37.3.
Not investment advice. Open the AQST and CHRW stock pages for the full models.
Not investment advice.